Sire Group Ltd. 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-21 08:32 am Unchanged |
2024-08-19 | 13D | Titan Pharmaceuticals, Inc. TTNP |
Sire Group Ltd. | 150,087 14.100% |
0 (Unchanged) |
Filing |
| 2024-04-05 4:34 pm Purchase |
2024-04-05 | 13D | Titan Pharmaceuticals, Inc. TTNP |
Sire Group Ltd. | 150,087 14.100% |
150,087 (New Position) |
Filing |